Evidence map›Paper›PMID 26439382›Full record

ArticlePLoS computational biology2015

Analyzing and Quantifying the Gain-of-Function Enhancement of IP3 Receptor Gating by Familial Alzheimer's Disease-Causing Mutants in Presenilins.

Don-On Daniel Mak, King-Ho Cheung, Patrick Toglia, J Kevin Foskett, Ghanim Ullah

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Upregulated CaCells · 2022
    Article
  6. Review
  7. Regulation of longevity by depolarization-induced activation of PLC-β-IPProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Emergence of ion channel modal gating from independent subunit kinetics.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Modelling modal gating of ion channels with hierarchical Markov models.Proceedings. Mathematical, physical, and engineering sciences · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Don-On Daniel MakDepartment of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
King-Ho CheungDepartment of Physiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Patrick TogliaDepartment of Physics, University of South Florida, Tampa, Florida, United States of America.
J Kevin FoskettDepartment of Physiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Ghanim UllahDepartment of Physics, University of South Florida, Tampa, Florida, United States of America.
University of Pennsylvania · USUniversity of South Florida · USUniversity of Hong Kong · HK

Funding

Multi-scale observation and modeling of IP3/Ca signalingR01GM065830 · NIGMS · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI MAK, DON-ON DANIEL, PARKER, IAN · 2002 to 2017
$10.7M
MOLECULAR PHYSIOLOGY OF MAMMALIAN INSP3 RECEPTORSR01MH059937 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI FOSKETT, JAMES KEVIN · 2000 to 2014
$5.0M
NIGMS NIH HHS GM065830NIGMS NIH HHS R01 GM065830NIMH NIH HHS MH059937NIMH NIH HHS R01 MH059937
6 · The paper itself

Abstract

Familial Alzheimer's disease (FAD)-causing mutant presenilins (PS) interact with inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) Ca(2+) release channels resulting in enhanced IP3R channel gating in an amyloid beta (Aβ) production-independent manner. This gain-of-function enhancement of IP3R activity is considered to be the main reason behind the upregulation of intracellular Ca(2+) signaling in the presence of optimal and suboptimal stimuli and spontaneous Ca(2+) signals observed in cells expressing mutant PS. In this paper, we employed computational modeling of single IP3R channel activity records obtained under optimal Ca(2+) and multiple IP3 concentrations to gain deeper insights into the enhancement of IP3R function. We found that in addition to the high occupancy of the high-activity (H) mode and the low occupancy of the low-activity (L) mode, IP3R in FAD-causing mutant PS-expressing cells exhibits significantly longer mean life-time for the H mode and shorter life-time for the L mode, leading to shorter mean close-time and hence high open probability of the channel in comparison to IP3R in cells expressing wild-type PS. The model is then used to extrapolate the behavior of the channel to a wide range of IP3 and Ca(2+) concentrations and quantify the sensitivity of IP3R to its two ligands. We show that the gain-of-function enhancement is sensitive to both IP3 and Ca(2+) and that very small amount of IP3 is required to stimulate IP3R channels in the presence of FAD-causing mutant PS to the same level of activity as channels in control cells stimulated by significantly higher IP3 concentrations. We further demonstrate with simulations that the relatively longer time spent by IP3R in the H mode leads to the observed higher frequency of local Ca(2+) signals, which can account for the more frequent global Ca(2+) signals observed, while the enhanced activity of the channel at extremely low ligand concentrations will lead to spontaneous Ca(2+) signals in cells expressing FAD-causing mutant PS.

Indexed as

Ion Channel GatingModels, BiologicalAlzheimer DiseaseAnimalsCalciumCalcium SignalingComputer SimulationHumansInositol 1,4,5-Trisphosphate ReceptorsInsectaModels, ChemicalPresenilinsCalciumInositol 1,4,5-Trisphosphate ReceptorsPresenilins

Identifiers

PMID26439382
PMCPMC4595473
OpenAlexW2266629359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.